The TXNIP protein regulates intra- and extra-cellular reduction-oxidation cycles [70, 71] and genetic variations in this gene have previously been shown to be associated with hypertriglyceridemia in individuals with T2D [72]. Here, TXNIP is linked to hypertriglyceridemia.